Sodium channel blockers: the size/solubility hypothesis revisited

Area of Science:

• Cardiovascular Pharmacology
• Molecular Biophysics
• Ion Channel Physiology

Background:

• Sodium channels are crucial for cardiac electrical activity.
• Drug interactions can alter sodium channel function, affecting heart rhythm.
• Understanding factors influencing sodium channel recovery is vital for drug development.

Purpose of the Study:

• To re-examine the influence of drug size on sodium channel recovery rates in heart tissue.
• To identify a more accurate predictor of drug-induced changes in repriming kinetics.
• To develop a quantitative model for sodium channel recovery time.

Main Methods:

• Re-evaluation of drug size influence on sodium channel recovery.
• Utilizing a drug dimension based on the end-on molecular view.
• Developing a quantitative model coupling proton exchange kinetics with drug size-dependent processes.

Main Results:

• Drug dimension, specifically the end-on molecular view, better explains size dependence of repriming kinetics than molecular weight.
• A quantitative model was developed linking proton exchange kinetics to drug size-dependent recovery from inactivation.
• Wider aromatic ends of drugs were found to significantly slow the rate of recovery from inactivation.

Conclusions:

• Molecular dimension, particularly the end-on view, is a critical determinant of drug effects on sodium channel recovery.
• The developed model provides a mechanistic link between drug structure and ion channel kinetics.
• Findings have implications for designing cardiac drugs with predictable recovery profiles.